Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
Novelty
Mechanistic
Druggability
Priority
75%
Importance
Tractability
Market price
50%

Description

The debate highlighted that TFEB effects vary by cell type and disease context, but specific safety windows for neurons versus glia remain undefined. This knowledge gap prevents rational dosing strategies for TFEB-targeted therapeutics.

Source: Debate session sess_SDA-2026-04-03-gap-debate-20260403-222617-8eb5bdbc (Analysis: SDA-2026-04-03-gap-debate-20260403-222617-8eb5bdbc)